GC, MDGC
GC-MS reveals biomarker for CF Ps aeruginosa infections
Nov 09 2010
Writing in BMC Pulmonary Medicine, researchers from the University of Otago, Leipzig University and Canterbury District Health Board in Christchurch, New Zealand, describe their use of GC-MS to investigate whether 2-aminoacetophenone (2-AA) is specific to Ps aeruginosa conditions.
They explain that 2-AA, a microbial volatile organic compound, is known to be responsible for the grape-like odour that accompanies Ps aeruginosa in CF patients.
Using a breath test to detect its presence, they found sensitivity of 93.8 per cent and specificity of 69.2 per cent when comparing a group of CF participants with a control population.
"Our results report 2-AA as a promising breath biomarker for the detection of Ps aeruginosa infections in the CF lung," they conclude.
The periodical addresses all aspects of pharmaceutical therapy for pulmonary diseases, including their diagnosis and prevention.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Sep 04 2024 Chiba, Tokyo, Japan